VEGFA and neoplasm: In particular, paclitaxel treatment has been shown to up-regulate VEGF expression, increase mobilization of circulating endothelial cells, induce production of endothelial cell progenitors, and enhance tumor-cell homing and adhesion to endothelial cells [17, 40-42].